KYTX
Kyverna Therapeutics, Inc. Common Stock
NASDAQ: KYTX · HEALTHCARE · BIOTECHNOLOGY
$9.47
+2.82% today
Updated 2026-05-06
Market cap
$557.48M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-3.64
Dividend yield
—
52W range
$2 – $14
Volume
0.9M
Kyverna Therapeutics, Inc. Common Stock (KYTX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-64.70%
ROA
-35.50%
Debt/equity
0.03x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2021 | $5.66M | $-26.35M | 100.00% | -465.81% | -465.88% |
| 2022 | $7.03M | $-28.89M | 100.00% | -418.28% | -411.29% |
| 2023 | $0.00 | $-60.37M | — | — | — |
| 2024 | $0.00 | $-127.48M | — | — | — |
| 2025 | $0.00 | $-161.31M | — | — | — |